本页面由Tiger Trade Technology Pte. Ltd.提供服务

Karyopharm Therapeutics Inc.

0.5092
-0.0958-15.83%
成交量:70.58万
成交额:38.39万
市值:1,154.00万
市盈率:-0.04
高:0.6047
开:0.5937
低:0.5082
收:0.6050
52周最高:10.99
52周最低:0.5082
股本:2,266.29万
流通股本:1,600.81万
量比:0.79
换手率:4.41%
股息:- -
股息率:- -
每股收益(TTM):-13.0816
每股收益(LYR):-17.9300
净资产收益率:-891.05%
总资产收益率:-47.61%
市净率:-0.03
市盈率(LYR):-0.03

数据加载中...

2026/10/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/09/25

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/09/25

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/09/18

重要事件披露

Form 8-K - Current report
2026/09/11

重要事件披露

Form 8-K - Current report
2026/09/04

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/31

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/31

重要事件披露

Form 8-K - Current report
2026/07/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

重要事件披露

Form 8-K - Current report
2026/06/05

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans